-
(2S,5S)-2,5-diamino-6-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]hexanoic acid
-
ChemBase ID:
133647
-
Molecular Formular:
C15H23N7O5
-
Molecular Mass:
381.38702
-
Monoisotopic Mass:
381.17606687
-
SMILES and InChIs
SMILES:
c1nc(c2c(n1)n(cn2)[C@H]1[C@@H]([C@@H]([C@H](O1)C[C@H](CC[C@@H](C(=O)O)N)N)O)O)N
Canonical SMILES:
N[C@H](C[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc2c1ncnc2N)CC[C@@H](C(=O)O)N
InChI:
InChI=1S/C15H23N7O5/c16-6(1-2-7(17)15(25)26)3-8-10(23)11(24)14(27-8)22-5-21-9-12(18)19-4-20-13(9)22/h4-8,10-11,14,23-24H,1-3,16-17H2,(H,25,26)(H2,18,19,20)/t6-,7-,8+,10+,11+,14+/m0/s1
InChIKey:
LMXOHSDXUQEUSF-YECHIGJVSA-N
-
Cite this record
CBID:133647 http://www.chembase.cn/molecule-133647.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
(2S,5S)-2,5-diamino-6-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]hexanoic acid
|
|
|
IUPAC Traditional name
|
|
Synonyms
|
5′-Deoxy-5′-(1,4-diamino-4-carboxybutyl)adenosine
|
A-9145
|
Adenosylornithine
|
Antibiotic 32232RP
|
Sinefungin
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
1.9477124
|
H Acceptors
|
11
|
H Donor
|
6
|
LogD (pH = 5.5)
|
-7.964581
|
LogD (pH = 7.4)
|
-6.847281
|
Log P
|
-5.1386905
|
Molar Refractivity
|
92.6784 cm3
|
Polarizability
|
36.682793 Å3
|
Polar Surface Area
|
208.65 Å2
|
Rotatable Bonds
|
7
|
Lipinski's Rule of Five
|
false
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
S8559
|
Biochem/physiol Actions Sinefungin blocks the methylation of bases in DNA and RNA, such as 5-methylcytosine or N6-methyladenosine, suggesting a role in gene expression. In addition, sinefugin is involved in physiological processes such as aging and carcinogenesis. Sinefungin blocks the methylation of bases in DNA and RNA, such as 5-methylcytosine or N6-methyladenosine, suggesting a role in gene expression. In addition, sinefugin is involved in physiological processes such as aging and carcinogenesis.Methylation inhibition by sinefugin is often accompanied by an altered rate of cytosine deamination that is coupled to transition mutation in the DNA. Sinefugin inhibits Epstein-Barr viral activity and this inhibition is related to the change in DNA methylation and gene expression. It can cause a rate change in several restriction DNA endonuclease activities, including Mme I, which is not connected to the inhibition of the methytransferase activity. |
PATENTS
PATENTS
PubChem Patent
Google Patent